We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-13.49%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$42.1B
AUM Growth
-$7.13B
Cap. Flow
+$617M
Cap. Flow %
1.47%
Top 10 Hldgs %
24.6%
Holding
2,253
New
45
Increased
584
Reduced
402
Closed
95

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$209M
2
T icon
AT&T
T
+$156M
3
XOM icon
ExxonMobil
XOM
+$122M
4
JNJ icon
Johnson & Johnson
JNJ
+$84.2M
5
WMT icon
Walmart Inc
WMT
+$77.1M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 18.92%
3 Financials 13.22%
4 Consumer Discretionary 8.69%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWTX icon
2176
Edgewise Therapeutics
EWTX
$4.39B
-662,526
Closed -$6.43M
GDS icon
2177
GDS Holdings
GDS
$6.34B
-7,000
Closed -$275K
GEVO icon
2178
Gevo
GEVO
$397M
-68,740
Closed -$322K
HSBC icon
2179
HSBC
HSBC
$355B
-446,413
Closed -$15.3M
INO icon
2180
Inovio Pharmaceuticals
INO
$79.8M
-5,116
Closed -$220K
IWD icon
2181
iShares Russell 1000 Value ETF
IWD
$82B
-97,000
Closed -$16.1M
LAB icon
2182
Standard BioTools
LAB
$326M
-80
Closed
LIDR icon
2183
AEye
LIDR
$52.3M
-2,009
Closed -$330K
MGNX icon
2184
MacroGenics
MGNX
$235M
-13,440
Closed -$118K
MVST icon
2185
Microvast
MVST
$267M
-26,520
Closed -$178K
NAUT icon
2186
Nautilus Biotechnolgy
NAUT
$215M
-134,695
Closed -$585K
NOMD icon
2187
Nomad Foods
NOMD
$1.64B
-233
Closed -$5K
NUVL
2188
DELISTED
Nuvalent
NUVL
-60,000
Closed -$834K
ADAM
2189
Adamas Trust
ADAM
$777M
-43,575
Closed -$636K
OMER icon
2190
Omeros
OMER
$709M
-19,360
Closed -$116K
OPK icon
2191
Opko Health
OPK
$921M
-23,210
Closed -$80K
PASG icon
2192
Passage Bio
PASG
$15.9M
-664
Closed -$41K
PRAX icon
2193
Praxis Precision Medicines
PRAX
$9.07B
-291
Closed -$45K
PRCH icon
2194
Porch Group
PRCH
$1.3B
-19,340
Closed -$134K
QNCX icon
2195
Quince Therapeutics
QNCX
$17.5M
-165
Closed -$205K
REAL icon
2196
The RealReal
REAL
$1.34B
-19,070
Closed -$138K
REKR icon
2197
Rekor Systems
REKR
$83.8M
-22,860
Closed -$104K
REYN icon
2198
Reynolds Consumer Products
REYN
$5.4B
-1
Closed
SPRY icon
2199
ARS Pharmaceuticals
SPRY
$590M
-346,024
Closed -$1.22M
TSHA icon
2200
Taysha Gene Therapies
TSHA
$1.59B
-1,410
Closed -$9K

Similar funds

Ensign Peak Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Ensign Peak Advisors held 2,253 positions worth $42.1B, down 14% from $49.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q2 2022 filing shows 45 new, 584 increased, 402 reduced and 95 closed positions. Its largest new stake was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M. The largest sale was iShares Russell 2000 ETF, an estimated $209M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2022 buy was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M.
  • Ensign Peak Advisors added most to Merck in Q2 2022, an estimated $209M increase.
  • Ensign Peak Advisors's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $209M.
  • Ensign Peak Advisors fully exited VMware, Inc in Q2 2022, selling an estimated $20.8M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $42.1B portfolio in Q2 2022.
  • Ensign Peak Advisors opened 45 new positions and closed 95 in Q2 2022.
  • Ensign Peak Advisors's portfolio value fell 14% quarter-over-quarter to $42.1B.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.